Overview

A Study of Combination Therapies to Treat COVID-19 Infection

Status:
Withdrawn
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study seeks to determine whether dual or quadruple therapy is more effective in treating COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
ProgenaBiome
Collaborator:
Big Corona Ltd.
Treatments:
Azithromycin
Hydroxychloroquine
Lopinavir
Ritonavir